Antibodies and Immunology

Antibodies in Research

Antibodies are used to identify antigens (e.g., pathogens) and neutralize them inside the body. This article looks at the role of antibodies in research.

An Introduction to Developmental Immunology

An Introduction to Reproductive Immunology

Monoclonal Antibodies versus Polyclonal Antibodies

Immunology of Infectious Diseases

An Introduction to Autoimmunity

Allergies and the Immune System

What are Therapeutic Antibodies?

Research Developments in Monoclonal Antibodies

What are Monoclonal Antibodies?

The Immunology of Organ Transplantation

See more featured articles »

What is the Clinical Impact of HLA Antibodies?

Antibody-Antigen Recognition- How Does it Work?

Creating a Nanobody Library with PCR

Recent Advancements in Monoclonal Antibodies

Innate vs Adaptive Immune Responses

Purifying Antibodies Using Ion Exchange Chromatography

VHH Antibodies (Nanobodies) Advantages and Limitations

What are Antibody-Escape Mutant Viruses?

What are Antibody-Drug Conjugates?

Using Antibodies in Immune Deficiency Treatment

What is Immune Checkpoint Therapy?

What is Inflammatory Macrophage Polarisation?

Why are Women Four Times More Likely to be Affected by Autoimmune Diseases than Men?

What are Polyclonal Antibodies?

How does the Immune System Handle Viruses?

What are Recombinant Antibodies?

The Future of Monoclonal Antibodies

MB66 Application in Antibody Transfer

What are Bispecific Antibodies?

Are Antibodies our Antidepressants?

Developing Antibodies Using Yeast

Improving Antibody Affinity Using CRISPR

Rabbit Monoclonal Antibodies (RabMab) Benefits

Biochemistry of Antibody-Antigen Interactions

Role of Chemokines and Cytokines in Health and Disease

What are Humanized Immune System Models?

Immunopathogenic Mechanism in HIV

What is Immunoliposome Therapy?

What is Macrophage Polarization?

What are the differences between B and T Cells?

What are Inflammatory Cell Death Regulators?

What are Designer Antiviral Peptides?

Using Apps to Analyze Immunohistochemistry Results

How Does Immunochemistry Work?

How do Lateral Flow Immunoassays Work?

Difference Between a Paratope and an Epitope

Latest Antibodies and Immunology News and Research

Study decodes the activation mechanism of immune cells

Chemokines are small proteins that adhere to these chemokine receptors and regulate the behavior and movement of white blood cells.

17 Jun 2021

Commonly used antidepressant drugs can also help the immune system to attack cancer

A class of drug called monoamine oxidase inhibitors is commonly prescribed to treat depression; the medications work by boosting levels of serotonin, the brain's "happiness hormone."

10 Jun 2021

Gene therapy may be a safe and effective single-dose treatment for hypophosphatasia

A preclinical study led by scientists at Sanford Burnham Prebys has established that AAV8-TNAP-D10--a gene therapy that replaces a key enzyme found in bone--may be a safe and effective single-dose treatment for hypophosphatasia (HPP).

8 Jun 2021

Antibody treatment reactivates the immune defense in advanced-stage cancer patients

Researchers at the University of Turku, Finland, showed that the antibody treatment reactivates the immune defense in patients with advanced-stage cancer. The treatment alters the function of the body's phagocytes and facilitates extensive activation of the immune system.

4 Jun 2021

NCI grants over $4.2 million to launch the Cancer Epitope Database and Analysis Resource

Researchers are about to welcome a new one-stop shop for crucial information on how the immune system targets cancers.

3 Jun 2021

Researchers discover what fuels the immune system’s “natural killers”

Natural killer (NK) cells, while having a name straight out of a Tarantino film, are allies of humans when it comes to combating cancer and infections.

3 Jun 2021

New consortium of bacteria can be used to treat aggressive colitis in humanized mouse models

A new study reported in Nature Communications shows that a consortium of bacteria, developed to complement lacking or poorly represented functions in the imbalanced microbiome of inflammatory bowel disease (IBD) patients, inhibited and treated chronic immune-mediated colitis in humanized mouse models.

31 May 2021

Novel drug is highly effective in preventing severe COVID-19 in mice

The drug diABZI -- which activates the body's innate immune response -- was highly effective in preventing severe COVID-19 in mice that were infected with SARS-CoV-2,

31 May 2021

Digital tool predicts protein stability in a cheaper, safer, and faster way

A cutting-edge digital tool that will make it cheaper, safer and faster for pharmaceutical companies to predict protein stability - a vital step in the development of new medicines - is being rolled out by scientists from the UK's University of Bath through their spin-out company, BLOC Labs.

31 May 2021

New data shows how exercise improves efficiency of energy production in muscle

Mitochondria are the cell's power plants and produce the majority of a cell's energy needs through an electrochemical process called electron transport chain coupled to another process known as oxidative phosphorylation.

28 May 2021

New wiki promotes development of innovative saliva-based diagnostic tests and customized treatment

The NIDCR has funded the creation of the Human Salivary Proteome Wiki, the first public platform that organizes information on each of the proteins found in human saliva.

27 May 2021

Study finds unique molecular mechanism by which Hepatitis C virus evades host’s immune system

Hepatitis C virus (HCV) can cause chronic liver infection, which can lead to irreparable liver damage and liver cancer.

27 May 2021

Neutralizing antibodies are produced after SARS-CoV-2 infection

A research group from Osaka University led by Professor Hisashi Arase and consisting of researchers from the Research Institute for Microbial Diseases, the Institute for Protein Research, the Immunology Frontier Research Center, the Center for Infectious Diseases, and the Graduate School of Medicine has discovered for the first time that both neutralizing antibodies that protect against infection as well as infection-enhancing antibodies that increase infectivity are produced after infection with SARS-CoV-2 by analyzing antibodies derived from COVID-19 patients.

26 May 2021